Fingerprint
Dive into the research topics of 'The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma
Nicholas Burwick, Michael Y. Zhang, Pilar de la Puente, Abdel Kareem Azab, Teresa S. Hyun, Melisa Ruiz-Gutierrez, Marilyn Sanchez-Bonilla, Tomoka Nakamura, Jeffrey J. Delrow, Vivian L. MacKay, Akiko Shimamura
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations